Home Healthcare Medical Devices US Hemodynamic Monitoring System Market to 2027

US Hemodynamic Monitoring System Market to 2027

Publisher: The Insight Partners
Publication Date: March, 2020
Healthcare / Medical Devices
Pages: 76
Delivery Format: PDF

Country Analysis and Forecasts by Type (Noninvasive Hemodynamic Monitoring System, Minimally Invasive Hemodynamic Monitoring System, Invasive Hemodynamic Monitoring System); Product (Monitors, Disposables); End User (Hospitals, Cath Labs, Home Care, Ambulatory Care Centers)

Report Features
Table of Contents
Pricing
Methodology
Request Sample
Compare Offers
Make an Offer

The US hemodynamic monitoring system market is anticipated to reach US$ 486.39 million by 2027 from US$ 292.28 million in 2019; it is projected to grow at a CAGR of 6.7% from 2020 to 2027.

The growth of the US hemodynamic monitoring system market is mainly ascribed to the factors such as increasing product developments and approvals, rising cardiovascular disease prevalence, and growing geriatric population. However, the risks associated with invasive hemodynamic monitoring systems are likely to hinder the growth of the market in the coming years. Despite this restraint, trend such as increasing preference for noninvasive devices is likely have a major impact on the market growth during the forecast period.

Hemodynamic monitoring involves the measurement of cardiac functions by determining blood circulation pattern inside veins, heart, and arteries. The monitoring of these parameters allows physicians to estimate the amount of oxygen that is being distributed in tissues and organs of the human body. Hemodynamic monitoring systems are used for measuring blood pressure inside veins, arteries, and heart. These systems are also used to measure blood flow and oxygen levels.

The prevalence of cardiovascular diseases in the US, which is a leading cause of death across the country, is much higher; >50% the population is suffering from some or other cardiovascular disease. According to the Centers for Disease Control and Prevention, every year, more than 0.6 million people die due to cardiovascular disease; this nearly accounts for one in every four deaths. Hypertension, obesity, and diabetes are the major conditions leading to the onset of cardiovascular disease among people. According to data published by American Heart Association on January 31, 2019, over 130 million or 45.1% of people are likely to have some form of cardiovascular disease by 2035 in the US.

The prevalence of cardiovascular diseases has propelled developments in the US healthcare sector, and various healthcare facilities across the country have increased the number of services. Hemodynamic monitoring systems assist them in offering better and advanced services to the majority of the cardiovascular disease patients admitted to intensive care units. These systems have become important tool for diagnosis as they assist physicians treating patients with tissue hypoperfusion conditions.

The invasive hemodynamic monitoring systems accounted for a larger share of the US hemodynamic monitoring system market, by type, in 2019. However, the noninvasive hemodynamic monitoring systems segment is expected to register a higher CAGR in the market during the forecast period.

Further, the disposables segment held largest share of the US hemodynamic monitoring system market, based on product, whereas the monitors segment is expected to witness the highest CAGR in the market during the forecast period.
Moreover, in 2019, the hospitals segment held the largest share of the US hemodynamic monitoring system market, by end user; it is further projected to dominate the market during the forecast period owing to the constant need for hospitals as primary healthcare centers.

A few of the significant primary and secondary sources studied for preparing this report on the US hemodynamic monitoring system market are National Cardiovascular Data Registry, and Food and Drug Administration (FDA).

Reasons to buy this report:
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US hemodynamic monitoring system market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the US hemodynamic monitoring system market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Select Plan

1 User License $3,000

Site License License $4,000

Are you looking for a Consultant?

Email Us

Get a Quote

Offer Amount (Per user license)	Retail price (Per user license)
$ .00	$3,000

US Hemodynamic Monitoring System Market to 2027

Are you looking for a Consultant?

Customers Who Viewed This Item Also Viewed